Representing Private Equity Sponsors in Healthcare Transactions: Best Practices for Due Diligence

Date:

Wednesday, April 10, 2013

Sponsor(s):

Speaker(s):

Geoffrey C. Cockrell and Amber McGraw Walsh, McGuireWoods LLP; Laura Keidan Martin, Katten Muchin Rosenman LLP

RSVP:

www.ali-cle.org or (800) 253-6397

Fee:

$199

Time:

12:30-2 pm EST

CLE Credits:

1.5-1.8 hrs

 

Without the infusion of private equity funds, many hospitals would not have the resources to continue operating. However, using private equity funds to finance healthcare transactions presents many regulatory and transactional issues. Such issues could potentially be avoided with thorough due diligence including investigating a target company’s operations; identifying potential regulatory and legal risks that may affect investment returns; and helping clients correct potential issues and suggesting alternative deal structures.